1. Severe adverse events by tyrosine kinase inhibitors decrease survival rates in patients with newly diagnosed chronic‐phase chronic myeloid leukemia. (23rd May 2018) Authors: Ota, Shuichi; Matsukawa, Toshihiro; Yamamoto, Satoshi; Ito, Shinichi; Shindo, Motohiro; Sato, Kazuya; Kondo, Takeshi; Kohda, Kyuhei; Sakai, Hajime; Mori, Akio; Takahashi, Tohru; Ikeda, Hiroshi; Kuroda, Hiroyuki; Haseyama, Yoshihito; Yamamoto, Masaki; Sarashina, Takeo; Yoshida, Makoto; Kobayashi, ... Journal: European journal of haematology Issue: Volume 101:Number 1(2018) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗